Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€5.88
25.01.21
€16.00
25.01.22
-15.72%
26.01.22

buy
GW Pharmaceuticals plc ADR

Start price
Target price
Perf. (%)
€117.00
24.01.21
€140.00
24.01.22
56.41%
21.11.21

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€63.50
24.01.21
-
24.01.22
-15.72%
11.03.21

Could be worthwhile Investment >10% per year
buy
Evolus Inc

Start price
Target price
Perf. (%)
€6.43
24.01.21
-
24.01.22
-22.55%
25.01.22

buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€17.00
24.01.21
-
24.01.22
-22.92%
25.01.22

buy
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€351.00
23.01.21
€3,000.0
23.01.22
-86.89%
24.01.22

buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€4.85
23.01.21
€50.00
23.01.22
-9.65%
24.01.22

buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€13.36
23.01.21
€100.00
23.01.22
-77.10%
24.01.22

Could be very worthwhile Investment >20% year
buy
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.62
23.01.21
€60.00
23.01.22
-81.94%
24.01.22

Could be very worthwhile Investment >20% year
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€3.98
23.01.21
€30.00
23.01.22
-60.05%
24.01.22

Could be very worthwhile Investment >20% year
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.19
23.01.21
€20.00
23.01.22
-51.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€75.60
23.01.21
-
23.01.22
-75.74%
08.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good culture
Future proof or reliable business model
buy
Teligent Inc.

Start price
Target price
Perf. (%)
€0.99
23.01.21
-
23.01.22
-97.97%
24.01.22

Could be very worthwhile Investment >20% year
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€31.33
23.01.21
-
23.01.22
-55.15%
24.01.22

Could be very worthwhile Investment >20% year
buy
Immunic Inc.

Start price
Target price
Perf. (%)
€14.50
23.01.21
€20.00
23.01.22
-41.24%
24.01.22

buy
Celsion Corp.

Start price
Target price
Perf. (%)
€19.65
23.01.21
-
23.01.22
-48.47%
19.11.21

buy
Adamis Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€105.00
23.01.21
-
23.01.22
-46.33%
19.11.21

buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
23.01.21
€3.00
23.01.22
-38.46%
24.01.22

Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€14.30
23.01.21
€18.50
23.01.22
-11.05%
24.01.22

First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€3,293.7
23.01.21
€0.000
23.01.22
-55.41%
26.06.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
Celsion Corp.

Start price
Target price
Perf. (%)
€19.65
23.01.21
€0.000
23.01.22
-14.50%
26.06.21

buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€29.75
22.01.21
€49.00
35.29%
20.03.21

Pharma Mar S.A.

Start price
Target price
Perf. (%)
€86.50
22.01.21
-
22.01.22
5.62%
03.05.21

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€54.63
22.01.21
-
22.01.22
3.20%
18.05.21